Journal article

A microRNA-21-mediated SATB1/S100A9/NF-κB axis promotes chronic obstructive pulmonary disease pathogenesis

RY Kim, KP Sunkara, KR Bracke, AG Jarnicki, C Donovan, AC Hsu, A Ieni, EL Beckett, I Galvão, S Wijnant, FLM Ricciardolo, A Di Stefano, TJ Haw, G Liu, AL Ferguson, U Palendira, PA Wark, G Conickx, P Mestdagh, GG Brusselle Show all

Science Translational Medicine | Published : 2021

Abstract

Chronic obstructive pulmonary disease (COPD) is the third leading cause of morbidity and death worldwide. Inhalation of cigarette smoke (CS) is the major cause in developed countries. Current therapies have limited efficacy in controlling disease or halting its progression. Aberrant expression of microRNAs (miRNAs) is associated with lung disease, including COPD. We performed miRNA microarray analyses of the lungs of mice with CS-induced experimental COPD. miR-21 was the second highest up-regulated miRNA, particularly in airway epithelium and lung macrophages. Its expression in human lung tissue correlated with reduced lung function in COPD. Prophylactic and therapeutic treatment with a spec..

View full abstract

University of Melbourne Researchers

Grants

Awarded by National Health and Medical Research Council of Australia


Awarded by Concerted Research Action of the Ghent University (BOF/GOA)


Awarded by Fund for Scientific Research in Flanders (FWO Vlaanderen)


Awarded by Fund for Scientific Research in Flanders (EOS contract)


Funding Acknowledgements

This work was supported by grants and fellowships from the National Health and Medical Research Council of Australia (1003593 to P.M.H. and 1079187 to P.M.H.), the University of Newcastle, the Hunter Medical Research Institute (to P.M.H.), the Concerted Research Action of the Ghent University (BOF/GOA, 01G02714 to K.R.B.), the Fund for Scientific Research in Flanders (FWO Vlaanderen, G052518N and EOS contract G0G2318N to K.R.B.), and fellowships from the Lung Foundation of Australia (to R.Y.K. and A.G.J.).